Atlas Trials

Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling

Clinical trial NCT02613962 · COMPLETED

Trial details

NCT number
NCT02613962
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed or Refractory Pediatric Tumor
Start date
2016-01-13
Primary completion
2022-11-16
Enrollment
791

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.